TransMedics Group shares last traded at $74.30, with a volume of 847,115 shares traded. Get TransMedics Group alerts:Trending Headlines about TransMedics GroupHere are the key news stories impacting TransMedics Group this week:Positive Sentiment: Revenue reached $189.95 million, up 20.7% year over year and ahead of the roughly $184 million consensus estimate. TransMedics Group Q2 2026 Earnings Call TranscriptThe company’s earnings call highlighted continued sales growth and demand for its organ-transplant technology. TransMedics Group Company Profile(Get Free Report)TransMedics Group, Inc is a medical device company headquartered in Andover, Massachusetts, that specializes in advanced organ preservation and transport systems for transplantation. Featured StoriesReceive News & Ratings for TransMedics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransMedics Group and related companies with MarketBeat.com's FREE daily email newsletter.